Cargando…
Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder, and bipolar disorder, has been shown to reduce positive and negative symptoms of schizophrenia. Clozapine, though beneficial in reducing the need for hospitalization, rehabilitation, and health care...
Autores principales: | Sussman, Melissa, Epifania, Michael, Eng, Derrick, Cho, Yun Jae, Steward, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914079/ https://www.ncbi.nlm.nih.gov/pubmed/33688445 http://dx.doi.org/10.1155/2021/8816390 |
Ejemplares similares
-
Clozapine-induced agranulocytosis
por: Mijovic, Aleksandar, et al.
Publicado: (2020) -
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles
por: Goldstein, Jacqueline I, et al.
Publicado: (2014) -
AGRANULOCYTOSIS DURING CLOZAPINE THERAPY
por: Jagadheesan, K., et al.
Publicado: (2000) -
Late Onset Clozapine Induced Agranulocytosis
por: Velayudhan, Rajmohan, et al.
Publicado: (2014) -
CLOZAPINE-INDUCED AGRANULOCYTOSIS AND USE OF G-CSF
por: Srinivasan, T.N., et al.
Publicado: (1998)